NCT04987528View on ClinicalTrials.gov

Pulmonary Fibrosis During Severe COVID-19 Pneumonia

Active, not recruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

March 11, 2020

Primary Completion Date

June 30, 2021

Study Completion Date

December 31, 2025

Conditions
Severe Acute Respiratory Syndrome Coronavirus 2Acute Respiratory Distress SyndromePulmonary Fibrosis
Interventions
DIAGNOSTIC_TEST

Aminoterminal type III peptide of procollagen

Serial Measurement of PIIINP in serum and/or BAL

DIAGNOSTIC_TEST

Lung computed tomography

Screening for the presence of reticulation or bronchiectasia within lung parenchyma

Trial Locations (1)

13003

Hopital Europeen Marseille, Marseille

All Listed Sponsors
lead

Hôpital Européen Marseille

OTHER